Skip to main content

What the FDA labels say about taking them together

Aspirin and revakinagene taroretcel-lwey

Revakinagene taroretcel-lwey's FDA label of August 26, 2026 names aspirin in its warnings and precautions section; the aspirin label PlainMeds reads does not name revakinagene taroretcel-lwey. The revakinagene taroretcel-lwey label: “Patients receiving antithrombotic medication may be at increased risk of vitreous hemorrhage.”

Check it at the source: the aspirin FDA label on DailyMed (effective September 9, 2025); the revakinagene taroretcel-lwey FDA label on DailyMed (effective August 26, 2026).

What does the aspirin label say about revakinagene taroretcel-lwey?

Aspirin's label (effective September 9, 2025) does not name revakinagene taroretcel-lwey in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Medique Products Aspirin), Unifirst First Aid Corporation, effective September 9, 2025 (SPL set 9b28fed0-a993-ca72-e053-2995a90ac7fd), via openFDA; the full label on DailyMed

What does the revakinagene taroretcel-lwey label say about aspirin?

Revakinagene taroretcel-lwey label, warnings and precautions

Patients receiving antithrombotic medication (e.g., oral anticoagulants, aspirin, nonsteroidal anti-inflammatory drugs) may be at increased risk of vitreous hemorrhage.

Source: FDA drug label (ENCELTO), Neurotech Pharmaceuticals, Inc., effective August 26, 2026 (SPL set 1ae9482a-b478-4e21-9166-b5fd52d3ef9c), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Aspirin generic labelers
0Revakinagene taroretcel-lwey generic labelers
AspirinRevakinagene taroretcel-lwey
Labeled forPain, Cough and cold, Fevern/a
Boxed warningNoNo
Pharmacy cost (NADAC)$0.0142 per tablet 81 mg tabletn/a
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?